Skip to main content

Gastric Cancer

Ausgabe 4/2019

Inhalt (30 Artikel)

Review Article

The therapeutic potential of metformin in gastric cancer

Sarah Courtois, Philippe Lehours, Emilie Bessède

Open Access Original Article

Mediterranean diet adherence and risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study

Maya Schulpen, Petra H. Peeters, Piet A. van den Brandt

Original Article

Unequal burden of mortality from gastric cancer in Brazil and its regions, 2000–2015

Lucia Libanez Bessa Campelo Braga, Alberto Novaes Ramos Jr., Manuel Bonfim Braga Neto, Anderson Fuentes Ferreira, Dulciene Maria Magalhães Queiroz, Danielle Calheiros Campelo Maia, Carlos Henrique Alencar, Jorg Heukelbach

Original Article

Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer

Tsutomu Namikawa, Nobuko Ishida, Sachi Tsuda, Kazune Fujisawa, Eri Munekage, Jun Iwabu, Masaya Munekage, Sunao Uemura, Shigehiro Tsujii, Takahiko Tamura, Tomoaki Yatabe, Hiromichi Maeda, Hiroyuki Kitagawa, Michiya Kobayashi, Kazuhiro Hanazaki

Original Article

MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression

Wei Guo, Xiaoliang Liang, Lei Liu, Yanli Guo, Supeng Shen, Jia Liang, Zhiming Dong

Original Article

Gastric lymphatic flows may change before and after endoscopic submucosal dissection: in vivo porcine survival models

Kyoko Nohara, Osamu Goto, Hiroya Takeuchi, Motoki Sasaki, Tadateru Maehata, Naohisa Yahagi, Yuko Kitagawa

Original Article

Genome-wide long non-coding RNAs identified a panel of novel plasma biomarkers for gastric cancer diagnosis

Rui Zheng, Jiayuan Liang, Jiafei Lu, Shuwei Li, Gang Zhang, Xiaowei Wang, Mengting Liu, Weizhi Wang, Haiyan Chu, Guoquan Tao, Qinghong Zhao, Meilin Wang, Mulong Du, Fulin Qiang, Zhengdong Zhang

Original Article

Identification of early genetic changes in well-differentiated intramucosal gastric carcinoma by target deep sequencing

Takashi Yoshida, Tatsuya Yamaguchi, Shinya Maekawa, Shinichi Takano, Toru Kuno, Keisuke Tanaka, Fumihiko Iwamoto, Yuya Tsukui, Shoji Kobayashi, Yukiko Asakawa, Hiroko Shindo, Mitsuharu Fukasawa, Yasuhiro Nakayama, Taisuke Inoue, Tomoyoshi Uetake, Masahiko Ohtaka, Tadashi Sato, Kunio Mochizuki, Nobuyuki Enomoto

Original Article

Effect of double-layer structure in intramucosal gastric signet-ring cell carcinoma on lymph node metastasis: a retrospective, single-center study

Katsuyuki Murai, Kohei Takizawa, Tadakazu Shimoda, Shougo Fujii, Takashi Sugino, Masao Yoshida, Noboru Kawata, Masaki Tanaka, Naomi Kakushima, Masanori Terashima, Hiroyuki Ono

Original Article

A novel TNM staging system for gastric cancer based on the metro-ticket paradigm: a comparative study with the AJCC-TNM staging system

Jun Lu, Zhi-Fang Zheng, Wei Wang, Jian-Wei Xie, Jia-Bin Wang, Jian-Xian Lin, Qi-Yue Chen, Long-Long Cao, Mi Lin, Ru-Hong Tu, Zhi-Wei Zhou, Chang-Ming Huang, Chao-Hui Zheng, Ping Li

Original Article

Association between UGT1A1 gene polymorphism and safety and efficacy of irinotecan monotherapy as the third-line treatment for advanced gastric cancer

Toshifumi Yamaguchi, Satoru Iwasa, Hirokazu Shoji, Yoshitaka Honma, Atsuo Takashima, Ken Kato, Tetsuya Hamaguchi, Kazuhide Higuchi, Narikazu Boku

Original Article

Predictive value of MLH1 and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer

Tadayoshi Hashimoto, Yukinori Kurokawa, Tsuyoshi Takahashi, Yasuhiro Miyazaki, Koji Tanaka, Tomoki Makino, Makoto Yamasaki, Kiyokazu Nakajima, Jun-ichiro Ikeda, Masaki Mori, Yuichiro Doki

Original Article

Predictive factors for hyperprogressive disease during nivolumab as anti-PD1 treatment in patients with advanced gastric cancer

Akinori Sasaki, Yoshiaki Nakamura, Saori Mishima, Akihito Kawazoe, Yasutoshi Kuboki, Hideaki Bando, Takashi Kojima, Toshihiko Doi, Atsushi Ohtsu, Takayuki Yoshino, Takeshi Kuwata, Tetsuo Akimoto, Kohei Shitara

Original Article

Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer

Manish A. Shah, Yoon-Koo Kang, Peter C. Thuss-Patience, Atsushi Ohtsu, Jaffer A. Ajani, Eric Van Cutsem, Silke Hoersch, Marie-Laurence Harle-Yge, Sanne Lysbet de Haas

Open Access Original Article

Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial

Toshihiko Doi, Satoru Iwasa, Kei Muro, Taroh Satoh, Shuichi Hironaka, Taito Esaki, Tomohiro Nishina, Hiroki Hara, Nozomu Machida, Yoshito Komatsu, Yasuhiro Shimada, Satoshi Otsu, Shin Shimizu, Morihiro Watanabe

Open Access Original Article

Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study

Yung-Jue Bang, Yoon-Koo Kang, Daniel V. Catenacci, Kei Muro, Charles S. Fuchs, Ravit Geva, Hiroki Hara, Talia Golan, Marcelo Garrido, Shadia I. Jalal, Christophe Borg, Toshihiko Doi, Harry H. Yoon, Mary J. Savage, Jiangdian Wang, Rita P. Dalal, Sukrut Shah, Zev A. Wainberg, Hyun Cheol Chung

Original Article

Long-term outcomes and prognostic factors with non-curative endoscopic submucosal dissection for gastric cancer in elderly patients aged ≥ 75 years

Yosuke Toya, Masaki Endo, Shotaro Nakamura, Risaburo Akasaka, Shunichi Yanai, Keisuke Kawasaki, Keisuke Koeda, Makoto Eizuka, Yasuko Fujita, Noriyuki Uesugi, Kazuyuki Ishida, Tamotsu Sugai, Takayuki Matsumoto

Original Article

Surgical risk and benefits of laparoscopic surgery for elderly patients with gastric cancer: a multicenter prospective cohort study

Michitaka Honda, Hiraku Kumamaru, Tsuyoshi Etoh, Hiroaki Miyata, Yuichi Yamashita, Kazuhiro Yoshida, Yasuhiro Kodera, Yoshihiro Kakeji, Masafumi Inomata, Hiroyuki Konno, Yasuyuki Seto, Seigo Kitano, Masahiko Watanabe, Naoki Hiki

Original Article

Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset

Shogo Hayashi, Mitsuro Kanda, Seiji Ito, Yoshinari Mochizuki, Hitoshi Teramoto, Kiyoshi Ishigure, Toshifumi Murai, Takahiro Asada, Akiharu Ishiyama, Hidenobu Matsushita, Chie Tanaka, Daisuke Kobayashi, Michitaka Fujiwara, Kenta Murotani, Yasuhiro Kodera

Original Article

Impact of preoperative wait time on survival in patients with clinical stage II/III gastric cancer

Kenichiro Furukawa, Tomoyuki Irino, Rie Makuuchi, Yusuke Koseki, Kenichi Nakamura, Yuhei Waki, Keiichi Fujiya, Hayato Omori, Yutaka Tanizawa, Etsuro Bando, Taiichi Kawamura, Masanori Terashima

Original Article

Prospective feasibility study for single-tracer sentinel node mapping by ICG (indocyanine green) fluorescence and OSNA (one-step nucleic acid amplification) assay in laparoscopic gastric cancer surgery

Yoshiaki Shoji, Koshi Kumagai, Satoshi Kamiya, Satoshi Ida, Souya Nunobe, Manabu Ohashi, Shoichi Yoshimizu, Yusuke Horiuchi, Toshiyuki Yoshio, Akiyoshi Ishiyama, Toshiaki Hirasawa, Tomo Osako, Noriko Yamamoto, Junko Fujisaki, Takeshi Sano, Naoki Hiki

Original Article

Pylorus-preserving gastrectomy for early cancer involving the upper third: can we go higher?

Chun-Chao Zhu, Hui Cao, Felix Berlth, Jia Xu, Shin-Hoo Park, Hwi-Nyeong Choe, Yun-Suhk Suh, Seong-Ho Kong, Hyuk-Joon Lee, Woo-Ho Kim, Han-Kwang Yang

Case Report

Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer

Taro Funakoshi, Shin’ichi Miyamoto, Nobuyuki Kakiuchi, Mitsuhiro Nikaido, Takeshi Setoyama, Akira Yokoyama, Takahiro Horimatsu, Atsushi Yamada, Masako Torishima, Shinji Kosugi, Hidetaka Yamada, Haruhiko Sugimura, Hironori Haga, Yoshiharu Sakai, Seishi Ogawa, Hiroshi Seno, Manabu Muto, Tsutomu Chiba

Short Communication

Clinical implications of CTNNA1 germline mutations in asymptomatic carriers

Patrick R. Benusiglio, Chrystelle Colas, Erell Guillerm, Axelle Canard, Hélène Delhomelle, Mathilde Warcoin, Jérôme Bellanger, Mélanie Eyries, Mohamed Zizi, Jeanne Netter, Florent Soubrier, Yann Parc, Anne Mourregot, Aurélie Maran Gonzalez, Veronica Cusin, Jérôme A. Denis, Isabelle Coupier, Magali Svrcek, Florence Coulet

Correction

Correction to: Oncological safety of proximal gastrectomy for T2/T3 proximal gastric cancer

Masahiro Yura, Takaki Yoshikawa, Sho Otsuki, Yukinori Yamagata, Shinji Morita, Hitoshi Katai, Toshirou Nishida

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.